NuVasive received regulatory approval for the minimally disruptive posterior fixation device in July.
The company opened a Tokyo office in April, and surgeon proctors have started to schedule training courses and surgeries with the Precept.
More Articles on Devices:
Stryker Buys MAKO Surgical for $1.65B
Spinal Elements Celebrates Hero Allograft Anniversary, Donates $250k to Children’s Charities
Study: Roughened Titanium Alloy Surface Better Enhances Fusion Than Smooth
